memoria2015

Recommendations

Info

3 INCLIVA Global analysis Evolution of the last five periods is shown in the chart below. The remaining income corresponds to private sources of funding, clinical trial revenues and grants among others. The graph below shows this distribution of the year 2015. 28
INCLIVA Global analysis 3 3.3 Cooperative research networks The Carlos III Health Institute (Instituto de Salud Carlos III) develops – through the General Subdirection of Networks and Centers for the Cooperative Research – the creation of stable research network structures such as RETICS (Thematic Networks of Cooperative Research) and CIBER (Network of Centres for Biomedical Research). INCLIVA participates in many of these research structures through its associated groups. The following table shows the participation in scientific networks according to the prioritized research area, the center and its principal investigator. Research Area INCLIVA PI Scientific Network Reference Carlos Hermenegildo Caudevilla Red RIC RD12/0042/0052 Rafael Carmena Rodríguez CIBERdem CB07/08/0018 29 Cardiovascular Juan Sanchis Forés Red RIC RD12/0042/0010 Francisco Javier Chorro Gascó Red RIC RD12/0042/0048 Empar Lurbe i Ferrer CIBERobn CB06/03/0039 Oncology Ana Lluch Hernández RETICC RD12/0036/0070 Samuel Navarro Fos RETICC RD12/0036/0020 Esteban Morcillo Sánchez CIBERes CB06/06/0027 Federico V. Pallardó Catalayud CIBERrer CB06/07/0073 José Viña Ribes Red RETICEF RD12/0043/0029 Metabolism and Organ Damage Julio Sanjuán Arias CIBERsam CB07/09/006 Juan Vicente Esplugues Mota CIBERehd CB06/04/0071 Guillermo Sáez Tormo CIBERobn CB12/03/30016 Rafael Tabarés Seisdedos CIBERsam CB07/09/0021 Others Rafael Peris Bonet RETICC RD12/0036/0053
Page 1 and 2: SCIENTIFIC REPORT 2015
Page 3: Index i 1 2 3 4 5 6 7 8 1. Introduc
Page 7 and 8: Introduction 1 7 It is a big pleasu
Page 11: INCLIVA Health Research Institute 2
Page 14 and 15: 2 INCLIVA Health Research Institute
Page 20: 2 INCLIVA Health Research Institute
Page 25 and 26: INCLIVA Global analysis 3 3.1 Scien
Page 27: INCLIVA Global analysis 3 3.2. Fina
Page 31 and 32: INCLIVA Global analysis 3 Committee
Page 33 and 34: INCLIVA Global analysis 3 3.4.2 Kno
Page 37: Scientific activity 4
Page 40 and 41: 4 Scientific activity Scientific pr
Page 42 and 43: 4 Scientific activity Research Grou
Page 44 and 45: 4 Scientific activity 44 3. Ascaso
Page 48 and 49: 4 Scientific activity 48 8. Martín
Page 52 and 53: 4 Scientific activity 52 Study of t
Page 54 and 55: 4 Scientific activity Clínico Univ
Page 56 and 57: 4 Scientific activity 56 Strategic
Page 60 and 61: 4 Scientific activity 60 Sanchís J
Page 64 and 65: 4 Scientific activity 64 • RESEAR
Page 70 and 71: 4 Scientific activity 70 • PUBLIC
Page 72 and 73: 4 Scientific activity 72 rrez F, Sa
Page 74 and 75: 4 Scientific activity Strategic aim
Page 78 and 79:
4 Scientific activity Group on Tran
Page 80 and 81:
4 Scientific activity 80 10. Santas
Page 82 and 83:
4 Scientific activity 4.1.2 Oncolog
Page 84 and 85:
4 Scientific activity 84 Strategic
Page 86 and 87:
4 Scientific activity Research Grou
Page 88 and 89:
4 Scientific activity 88 10. Ferná
Page 90 and 91:
4 Scientific activity 90 Emerging r
Page 92 and 93:
4 Scientific activity 92 refractory
Page 94 and 95:
4 Scientific activity 94 Director(s
Page 96 and 97:
Page 98 and 99:
4 Scientific activity 98 González
Page 100 and 101:
4 Scientific activity Denkert C, Ma
Page 102 and 103:
Page 104 and 105:
4 Scientific activity 104 12. Díaz
Page 106 and 107:
Page 108 and 109:
4 Scientific activity 108 Thesis ti
Page 110 and 111:
Page 112 and 113:
4 Scientific activity 112 D, Bernal
Page 114 and 115:
Page 116 and 117:
4 Scientific activity cells to arse
Page 118 and 119:
Page 120 and 121:
4 Scientific activity 120 17. Xicoy
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
4 Scientific activity Reference: SA
Page 128 and 129:
Page 130 and 131:
4 Scientific activity Reference: FO
Page 132 and 133:
Page 134 and 135:
4 Scientific activity Reference: CB
Page 136 and 137:
Page 138 and 139:
4 Scientific activity 138 Thesis ti
Page 140 and 141:
4 Scientific activity Emerging rese
Page 142 and 143:
4 Scientific activity 142 Hervás S
Page 144 and 145:
Page 146 and 147:
4 Scientific activity •To develop
Page 148 and 149:
Page 150 and 151:
4 Scientific activity 150 Empirical
Page 152 and 153:
Page 154 and 155:
4 Scientific activity 154 Reference
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
4 Scientific activity • RESEARCH
Page 162 and 163:
Page 164 and 165:
4 Scientific activity 164 20. Gambi
Page 166 and 167:
Page 168 and 169:
4 Scientific activity 168 J, Núñe
Page 170 and 171:
4 Scientific activity 170 Being Ove
Page 172 and 173:
Page 174 and 175:
4 Scientific activity Clínico Univ
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
4 Scientific activity 180 9. Feigin
Page 182 and 183:
4 Scientific activity 4.1.4 Reprodu
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
4 Scientific activity 188 hesion to
Page 190 and 191:
4 Scientific activity 190 growth fa
Page 192 and 193:
4 Scientific activity Clínico Univ
Page 194 and 195:
Page 196 and 197:
4 Scientific activity 196 developme
Page 198 and 199:
4 Scientific activity Hospital divi
Page 200 and 201:
4 Scientific activity ablation as a
Page 202 and 203:
4 Scientific activity Title: Valida
Page 204 and 205:
4 Scientific activity 204 Sarriá B
Page 206 and 207:
4 Scientific activity Department of
Page 208 and 209:
4 Scientific activity 208 • THESI
Page 210 and 211:
4 Scientific activity 210 Ferreres
Page 212 and 213:
4 Scientific activity 212 • A new
Page 214 and 215:
4 Scientific activity 214 D, Freude
Page 216 and 217:
4 Scientific activity Department of
Page 218 and 219:
4 Scientific activity 4.3 Other sci
Page 220 and 221:
4 Scientific activity Estudio de la
Page 223 and 224:
Clinical trials and other studies 5
Page 225 and 226:
Page 227 and 228:
Page 231 and 232:
Initiatives for research promotion
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 245 and 246:
Highlights 7
Page 247:
Higlights 7 JULY INCLIVA and Lanzad
Page 250 and 251:
8 INCLIVA Solidary PROYECTO MAMA IN
Page 252 and 253:
8 INCLIVA Solidary nia Torre, Cesar
Page 256:
Avda. Menéndez Pelayo, 4 accesorio
show all

memoria2015

Create successful ePaper yourself

Delete template?

Save as template?